Back to company

Preo Pharma ApS: Financial statements 2021

CVR: 41191007

Preo Pharma ApS (CVR 41191007) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 294,880 and a net result of DKK 188,655 compared with DKK -120,084 the year before. Equity amounted to DKK 108,571. The solvency ratio was 28.8%.

Gross Profit
294,880 kr.
Profit/Loss
188,655 kr.
Equity
108,571 kr.
Total Assets
376,735 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-295 t.189 t.109 t.-
2020--161 t.-120 t.-80 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Preo Pharma ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Preo Pharma ApS publishes interim reportMay 25, 2021

Preo Pharma ApS has published its interim report for the period February 24, 2020 – December 31, 2020.

Preo Pharma ApS appoints new auditorFeb 24, 2021

As of February 24, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Preo Pharma ApS.

About Preo Pharma ApS

Preo Pharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2020 and dissolved in 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2022, the company reported a gross profit of DKK -41,283 and a net result of DKK -54,301 compared with DKK 188,655 the year before. Equity amounted to DKK 54,270.

Other financial years